鲍曼不动杆菌流行及治疗__培训课件.ppt

鲍曼不动杆菌流行及治疗__培训课件.ppt

  1. 1、本文档共76页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
High-dose ampicillin-sulbactam for MDRAB VAP Scand J Infect Dis 2007: 39: 38-43. 0.785 0.303 0.580 0.568 0.936 p value CRAB的治疗-多黏菌素 静脉应用多黏菌素治疗总有效率为57%~80%. 肾功能损害的发生率约为0~37%. 雾化吸入有助于减少全身用药的副作用,并在 局部组织达到较高的药物浓度. 仍需进一步临床对照研究证实. Clin Microbiol Rev 2008: 21: 538-582. A case: PDRAB meningitis cefoperazone/sulbactam 35d Polymyxin E Jian Li, et al. AAC, 2006, 50:2946–2950 Passage of ATCC 19606 in CAMHB with or without colistin Hetero resistant to colistin passages clinic AB in broth containing colistin increased the proportion of the resistant subpopulations from 10E-8 to 10E-4 isolates MIC Before induction After induction* 6mg/L 8mg/L 10mg/L 6mg/L 8mg/L 10mg/L 16301 1.5mg/L 10E-6 10E-6 10E-6 10E-5 10E-5 10E-5 16302 1.5mg/L 10E-8 10E-8 10E-8 10E-4 10E-4 10E-4 10305 1.5mg/L 10E-7 10E-8 10E-8 10E-5 10E-5 10E-5 *8mg/L * 48小时,64mg/L * 48小时 High resistance to colistin of MDRAB from Korea Considering the increasing use of colistin, independent but frequent emergence of colistin resistance in MDRAB is of great concern. Kwan Soo Ko, JAC 2007,60:1163-7 Young Kyoung Parka, DMID 2009, 64:43-51 BIG BUG! Colistin Good outcome to MDR AB infection,including: bacteremia、pneumonia、urinary tract infection、wound infection、 meningitis Only 10.8% CRAB were resistant to colistin in China Mainland Tigecycline: the saviour? 22 microbiological studies reporting data for 2384 Acinetobacter spp, 90% isolates (including MDR and CRAB) were susceptible 42 severely ill patients, tigecycline therapy (combination with other antibiotics in 28 patients) was effective in 32 cases In 3 cases, resistance to tigecycline developed during treatment Drosos EK, et al. JAC, 2008, 62:44-45 Tetracycline Susceptibility Testing in Isolates of Acinetobacte from a U.S. Military Hospital Kevin S. Akers, AAC, 2009, accepted Susceptibility of 73 IPM-I or R A. baumannii isolates to tigecycline S:6 isolates(8.2%),I: 6 isolates(8.2%),R:61 isolates(83.6%) Susceptibility of 43 IPM-S A. baumannii isolate

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档